HFA Premium Access

Clinical experience and safety of ferric carboxymaltose for treating iron deficiency in heart failure patients with mildly reduced and preserved left ventricular ejection fraction.

Congress Presentation

About the speaker

Doctor Alberto Esteban Fernandez

Severo Ochoa Hospital, Leganes (Spain)
3 presentations
0 follower

7 more presentations in this session

GDF15 is linked to congestion-related anorexia and weight loss in advanced HF

Speaker: Doctor V. Melenovsky (Prague, CZ)


Prognostic impact of co-morbidities on long-term prognosis in patients with reduced and preserved ejection fraction following acute myocardial infarction

Speaker: Assistant Professor L. Savic (Belgrade, RS)


Soluble transferrin receptor as a marker of tissue iron deficiency: impact on health-related quality of life in patients with heart failure without systemic iron deficiency or anaemia

Speaker: Mr R. Ramos Polo (Hospitalet De Llobregat, ES)


Infection risk with ferric derisomaltose compared to standard of care in patients with heart failure and iron deficiency: a prespecified analysis of the IRONMAN trial

Speaker: Professor P. Kalra (Portsmouth, GB)


Evaluation of intracranial circulation in patients in terminal stage of heart failure before and after heart transplantation

Speaker: Doctor J. Zizka (Prague, CZ)


Access the full session

Chronic heart failure - clinical

Speakers: Doctor A. Esteban Fernandez, Doctor V. Melenovsky, Assistant Professor L. Savic, Mr R. Ramos Polo, Professor P. Kalra...

About the event


Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by